{"id":205157,"name":"VIR BIOTECHNOLOGY, INC.","slug":"vir-biotechnology-inc","state":"CA","description":"Clinical Stage immunology company","totalSpending":1590000,"filings":22,"yearlySpending":[{"year":2020,"income":270000},{"year":2021,"income":340000},{"year":2022,"income":320000},{"year":2023,"income":310000},{"year":2024,"income":150000},{"year":2025,"income":200000}],"firms":["FORBES-TATE"],"lobbyists":["BARRETT THORNHILL","WESLEY WELCH","ZACHARY WILLIAMS","EDWARD RENO","KRISTINA DUNKLIN","DERRICK WHITE","CYNTHIA BROWN","ELIZABETH GREER","JEFFREY SADOSKY","FRANCESCA MCCRARY","RICHARD LOPEZ","PAUL DIOGUARDI","ADRIENNE SCHWEER","ARTHUR SIDNEY","MICHAEL WILLIAMS"],"issues":["GOV","HCR","BUD","TAX",null],"sampleDescriptions":["Healthcare initiatives related to novel antibody technology platform.","Issues related to H.R. 925 - The Heroes Act.","Healthcare initiatives related to novel antibody technology platform; Issues related to COVID funding; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.","Issues related to COVID funding.","Healthcare initiatives related to novel antibody technology platform; Issues related to COVID funding.","Issues related to research and development tax credit.","Issues related to biopharmaceutical research, development, and manufacturing for infectious disease products."],"years":[2020,2021,2022,2023,2024,2025]}